Bibliography
- Libby P , RidkerPM, MaseriA: Inflammation and atherosclerosis.Circulation105(9), 1135–1143 (2002).
- Fichtlscherer S , HeeschenC, ZeiherAM: Inflammatory markers and coronary artery disease.Curr. Opin. Pharmacol.4(2), 124–131 (2004).
- Lau D , BaldusS: Myeloperoxidase and its contributory role in inflammatory vascular disease.Pharmacol. Ther.111(1), 16–26 (2006).
- Ikitimur B , KaradagB: Role of myeloperoxidase in cardiology.Future Cardiol.6(5), 693–702 (2010).
- Stocker R , KeaneyJF Jr: Role of oxidative modifications in atherosclerosis. Physiol. Rev.84(4), 1381–1478 (2004).
- Carr AC , McCallMR, FreiB: Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection.Arterioscler. Thromb. Vasc. Biol.20(7), 1716–1723 (2000).
- Abu-Soud HM , HazenSL: Nitric oxide is a physiological substrate for mammalian peroxidases.J. Biol. Chem.275(48), 37524–37532 (2000).
- Xu J , XieZ, ReeceR, PimentalD, ZouMH: Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite.Arterioscler. Thromb. Vasc. Biol.26(12), 2688–2695 (2006).
- Nicholls SJ , HazenSL: The role of myeloperoxidase in the pathogenesis of coronary artery disease.Jpn J. Infect. Dis.57(5), S21–S22 (2004).
- Buffon A , BiasucciLM, LiuzzoG, D‘OnofrioG, CreaF, MaseriA: Widespread coronary inflammation in unstable angina.N. Engl. J. Med.347(1), 5–12 (2002).
- Zhang R , BrennanML, FuXet al. : Association between myeloperoxidase levels and risk of coronary artery disease.JAMA286(17), 2136–2142 (2001).
- Duzguncinar O , YavuzB, HazirolanTet al. : Plasma myeloperoxidase is related to the severity of coronary artery disease.Acta Cardiol.63(2), 147–152 (2008).
- Moldoveanu E , TanaseanuC, TanaseanuSet al. : Plasma markers of endothelial dysfunction in Type 2 diabetics.Eur. J. Intern. Med.17(1), 38–42 (2006).
- Eleuteri E , DiSA, RicciardoloFLet al. : Increased nitrotyrosine plasma levels in relation to systemic markers of inflammation and myeloperoxidase in chronic heart failure.Int. J. Cardiol.135(3), 386–390 (2009).
- Yunoki K , NarukoT, KomatsuRet al. : Relation of elevated levels of plasma myeloperoxidase to impaired myocardial microcirculation after reperfusion in patients with acute myocardial infarction.Am. J. Cardiol.105(7), 922–929 (2010).
- Kubala L , LuG, BaldusS, BerglundL, EiserichJP: Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.Clin. Chim. Acta394(1–2), 59–62 (2008).
- Ndrepepa G , BraunS, MehilliJ, vonBN, SchomigA, KastratiA: Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.Eur. J. Clin. Invest.38(2), 90–96 (2008).
- Miller M , MeadLA, KwiterovichPO Jr, Pearson TA: Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease. Am. J. Cardiol.65(1), 1–5 (1990).
- Apple FS , WuAH, MairJet al. : Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome.Clin. Chem.51(5), 810–824 (2005).
- Zouaoui Boudjeltia K , MoguilevskyN, LegssyerIet al. : Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation.Biochem. Biophys. Res. Commun.325(2), 434–438 (2004).
- Higashi Y , NomaK, YoshizumiM, KiharaY: Endothelial function and oxidative stress in cardiovascular diseases.Circ. J.73(3), 411–418 (2009).
- Baldus S , HeeschenC, MeinertzTet al. : Myeloperoxidase serum levels predict risk in patients with acute coronary syndrome.Circulation108(12), 1440–1445 (2003).
- Brennan ML , PennMS, VanLFet al. : Prognostic value of myeloperoxidase in patients with chest pain.N. Engl. J. Med.349(17), 1595–1604 (2003).
- Cavusoglu E , RuwendeC, EngCet al. : Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.Am. J. Cardiol.99(10), 1364–1368 (2007).
- Roman RM , WendlandAE, PolanczykCA: Myeloperoxidase and coronary arterial disease: from research to clinical practice.Arq. Bras. Cardiol.91(1), e11–e19 (2008).
- Sugiyama S , OkadaY, SukhovaGK, VirmaniR, HeineckeJW, LibbyP: Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.Am. J. Pathol.158(3), 879–891 (2001).
- Naruko T , UedaM, HazeKet al. : Neutrophil infiltration of culprit lesions in acute coronary syndromes.Circulation106(23), 2894–2900 (2002).
- Rudolph V , StevenD, GehlingUMet al. : Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease.Free Radic. Biol. Med.42(4), 460–465 (2007).
- Zhang C , ReiterC, EiserichJPet al. : L-arginine chlorination products inhibit endothelial nitric oxide production.J. Biol. Chem.276(29), 27159–27165 (2001).
- Zhang C , YangJ, JacobsJD, JenningsLK: Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases.Am. J. Physiol. Heart Circ. Physiol.285(6), H2563–H2572 (2003).
- Vita JA , BrennanML, GokceNet al. : Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.Circulation110(9), 1134–1139 (2004).
- Widlansky ME , GokceN, KeaneyJF Jr, Vita JA: The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol.42(7), 1149–1160 (2003).
- Vita JA , KeaneyJF Jr: Endothelial function: a barometer for cardiovascular risk. Circulation106(6), 640–642 (2002).
- Podrez EA , SchmittD, HoffHF, HazenSL: Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro.J. Clin. Invest.103(11), 1547–1560(1999).
- Yoshida H : [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].Rinsho. Byori.58(6), 622–630 (2010).
- Anselmi M , GarbinU, AgostoniPet al. : Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques.Atherosclerosis185(1), 114–120 (2006).
- Roman RM , CamargoPV, BorgesFK, RossiniAP, PolanczykCA: Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.Coron. Artery Dis.21(3), 129–136 (2010).